We are live on
!
Find out more
CSIC
Clifford Swan Investment Counsel Portfolio holdings
AUM
$2.94B
1-Year Est. Return
21.31%
This Fund
S&P 500
This Quarter
Est. Return
+3.33%
1 Year Est. Return
+21.31%
3 Year Est. Return
+60.82%
5 Year Est. Return
+91.5%
10 Year Est. Return
+310.89%
AUM
$1.49B
AUM Growth
+$14.8M
(+1%)
Cap. Flow
-$21.3M
Cap. Flow
% of AUM
-1.43%
Top 10 Holdings %
Top 10 Hldgs %
26.11%
Holding
292
New
11
Increased
58
Reduced
123
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$5.1M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$2.3M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
+$2.17M |
| 4 |
CERN
Cerner Corp
CERN
|
+$1.44M |
| 5 |
Abbott
ABT
|
+$1.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$8.83M |
| 2 |
Johnson Controls International
JCI
|
+$3.64M |
| 3 |
Hain Celestial
HAIN
|
+$1.67M |
| 4 |
United Parcel Service
UPS
|
+$1.48M |
| 5 |
Chevron
CVX
|
+$1.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.26% |
| 2 | Industrials | 16.44% |
| 3 | Healthcare | 14.09% |
| 4 | Financials | 11.79% |
| 5 | Consumer Staples | 11.01% |
Similar funds
BCF
VGM
CAM
MYLI
SCM
CCPM
HCC
BAM
Clifford Swan Investment Counsel's Q4 2016 Portfolio in Review
As of Q4 2016, Clifford Swan Investment Counsel held 292 positions worth $1.49B, up 1% from $1.48B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Clifford Swan Investment Counsel's Q4 2016 filing shows 11 new, 58 increased, 123 reduced and 11 closed positions. Its largest new stake was Adient: 17,329 shares worth $1.01M. The largest sale was Gilead Sciences, an estimated $8.83M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Healthcare.
- Clifford Swan Investment Counsel's largest Q4 2016 buy was Adient: 17,329 shares worth $1.01M.
- Clifford Swan Investment Counsel added most to Bristol-Myers Squibb in Q4 2016, an estimated $5.1M increase.
- Clifford Swan Investment Counsel's biggest Q4 2016 reduction was Gilead Sciences, cutting an estimated $8.83M.
- Clifford Swan Investment Counsel fully exited BlackRock Capital Investment Corporation in Q4 2016, selling an estimated $434K.
- Clifford Swan Investment Counsel's ten largest holdings make up 26% of its $1.49B portfolio in Q4 2016.
- Clifford Swan Investment Counsel opened 11 new positions and closed 11 in Q4 2016.
- Clifford Swan Investment Counsel's portfolio value rose 1% quarter-over-quarter to $1.49B.
Based on Clifford Swan Investment Counsel's 13F filing for Q4 2016, filed 6 Feb 2017.